Pfenex Company
Pfenex develops biosimilar therapeutics and novel vaccines for the treatment and prevention of critical human health issues.
%20.jpg)
%20.jpg)
Estimated Revenue:
$10M to $50M
Funding Status:
M&A
Industry:
PharmTech
Number Of Exists:
N/A
Technology:
Cancer
Founded Date:
2009
Investor Type:
N/A
Headquarters:
San Diego, California, United States
Employee Number:
11-50
Investment Stage:
N/A